NEW YORK (360Dx) – Vermillion reported today a 44 percent rise in first quarter revenues.
For the three months ended March 31, the Austin, Texas-based cancer diagnostics firm said that total revenues rose to $726,000 from $505,000 in the year-ago quarter.
Product revenues were $678,000, up from $505,000 in Q1 2016. Service revenues were $48,000. The company posted no service revenues in the year-ago quarter as it had not yet launched its Aspira IVD service business.